Panax quinquefolius polysaccharides ameliorate ulcerative colitis in mice induced by dextran sulfate sodium
- PMID: 37415978
- PMCID: PMC10321667
- DOI: 10.3389/fimmu.2023.1161625
Panax quinquefolius polysaccharides ameliorate ulcerative colitis in mice induced by dextran sulfate sodium
Abstract
This study aimed to investigate the ameliorative effect of the polysaccharides of Panax quinquefolius (WQP) on ulcerative colitis (UC) induced by dextran sulfate sodium (DSS) in mice and to explore its mechanism. Male C57BL/6J mice were randomly divided into the control group (C), model group (DSS), positive control mesalazine (100 mg/kg, Y) group, and low (50 mg/kg, L), medium (100 mg/kg, M) and high dose (200 mg/kg, H) of WQP groups. The UC model was induced by free drinking water with 2.5% DSS for 7 days. During the experiment, the general condition of the mice was observed, and the disease activity index (DAI) was scored. The conventional HE staining was used to observe pathological changes in mice's colon, and the ELISA method was used to detect the levels of interleukin-6 (IL-6), IL-4, IL-8, IL-10, IL-1β and tumor necrosis factor-α (TNF-α) in mice's colon. The changes in gut microbiota in mice were detected by high-throughput sequencing; the concentration of short-chain fatty acids (SCFAs) was determined by gas chromatography; the expression of related proteins was detected by Western blot. Compared with the DSS group, the WQP group showed a significantly lower DAI score of mice and an alleviated colon tissue injury. In the middle- and high-dose polysaccharides groups, the levels of pro-inflammatory cytokines IL-6, IL-8, IL-1β and TNF-α in the colonic tissue were significantly decreased (P<0.05), while the levels of IL-4 and IL-10 were significantly increased (P<0.05). The 16S rRNA gene sequencing results showed that different doses of WQP could regulate the composition and diversity of gut microbiota and improve its structure. Specifically, at the phylum level, group H showed an increased relative abundance of Bacteroidetes and a decreased relative abundance of Firmicutes compared with the DSS group, which was closer to the case in group C. At the family level, the relative abundance of Rikenellaceae in L, M and H groups increased significantly, close to that in group C. At the genus level, the relative abundance of Bacteroides, Shigella and Oscillospira in the H group increased significantly, while that of Lactobacillus and Prevotella decreased significantly. The high-dose WQP group could significantly increase the contents of acetic acid, propionic acid, butyric acid, and total SCFAs. Different doses of WQP also increased the expression levels of tight junction proteins ZO-1, Occludin and Claudin-1. To sum up, WQP can regulate the gut microbiota structure of UC mice, accelerate the recovery of gut microbiota, and increase the content of Faecal SCFAs and the expression level of tight junction proteins in UC mice. This study can provide new ideas for the treatment and prevention of UC and theoretical references for the application of WQP.
Keywords: 16S rRNA gene sequencing; Panax quinquefolius polysaccharides; gut microbiota; short-chain fatty acids; ulcerative colitis.
Copyright © 2023 Ren, Chen, Li, Zhang, Li, Liu and Sun.
Conflict of interest statement
Author K-CC was employed by company Goldenwell Biotech, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity.J Ethnopharmacol. 2023 Jan 10;300:115741. doi: 10.1016/j.jep.2022.115741. Epub 2022 Sep 24. J Ethnopharmacol. 2023. PMID: 36162543
-
2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.Biomed Pharmacother. 2021 May;137:111420. doi: 10.1016/j.biopha.2021.111420. Epub 2021 Feb 23. Biomed Pharmacother. 2021. PMID: 33761623
-
Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis.J Ethnopharmacol. 2024 May 23;326:117990. doi: 10.1016/j.jep.2024.117990. Epub 2024 Feb 27. J Ethnopharmacol. 2024. PMID: 38423412
-
Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice.Curr Microbiol. 2025 Mar 24;82(5):204. doi: 10.1007/s00284-025-04190-5. Curr Microbiol. 2025. PMID: 40126646 Review.
-
The Potential Role of Plant Polysaccharides in Treatment of Ulcerative Colitis.Pharmaceutics. 2024 Aug 16;16(8):1073. doi: 10.3390/pharmaceutics16081073. Pharmaceutics. 2024. PMID: 39204418 Free PMC article. Review.
Cited by
-
Research advancements and perspectives of inflammatory bowel disease: A comprehensive review.Sci Prog. 2024 Apr-Jun;107(2):368504241253709. doi: 10.1177/00368504241253709. Sci Prog. 2024. PMID: 38778725 Free PMC article. Review.
-
Comparative in silico and in vivo study of the antioxidant activity of lactoferrin, Geobacillus stearothermophilus, and Lactobacillus delbrueckii subsp. lactis against Rotavirus infection in male mice.BMC Microbiol. 2025 Mar 4;25(1):117. doi: 10.1186/s12866-025-03820-z. BMC Microbiol. 2025. PMID: 40038589 Free PMC article.
-
Microencapsulation and Probiotic Characterization of Lactiplantibacillus plantarum LM-20: Therapeutic Application in a Murine Model of Ulcerative Colitis.Nutrients. 2025 Feb 20;17(5):749. doi: 10.3390/nu17050749. Nutrients. 2025. PMID: 40077619 Free PMC article.
-
Immune dysregulation in ulcerative colitis: pathogenic mechanisms and therapeutic strategies of traditional Chinese medicine.Front Cell Dev Biol. 2025 Jun 5;13:1610435. doi: 10.3389/fcell.2025.1610435. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40538978 Free PMC article. Review.
-
Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.Front Immunol. 2024 Mar 28;15:1385907. doi: 10.3389/fimmu.2024.1385907. eCollection 2024. Front Immunol. 2024. PMID: 38605960 Free PMC article. Review.
References
-
- Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, et al. . Dietary guidance from the international organization for the study of inflammatory bowel diseases. Clin Gastroenterol hepatol: Off Clin Pract J Am Gastroenterol Assoc (2020) 18(6):1381–92. doi: 10.1016/j.cgh.2020.01.046 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical